Baculoviral vectors for gene delivery: A review

Current Gene Therapy

Volumn 8, Issue 1, 2008, Pages 54-65

  Hu, Yu Chen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BACULOVIRUS VECTOR; BUTYRIC ACID; CARCINOEMBRYONIC ANTIGEN; DIPHTHERIA TOXIN; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; LENTIVIRUS VECTOR; MACROGOL; MONOCLONAL ANTIBODY; NOCODAZOLE; PARVOVIRUS VECTOR; PLASMID VECTOR; RETROVIRUS VECTOR; RIBOZYME; SHORT HAIRPIN RNA; TRICHOSTATIN A; VALPROIC ACID; VINBLASTINE; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ADAPTIVE IMMUNITY; BACULOVIRUS EXPRESSION SYSTEM; CANCER GENE THERAPY; CANCER INHIBITION; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SYNTHESIS; EX VIVO GENE TRANSFER; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GLIOMA; HUMAN; IN VITRO GENE TRANSFER; IN VIVO GENE TRANSFER; INFLUENZA; INNATE IMMUNITY; INTRACELLULAR TRANSPORT; MAMMAL CELL; MOLECULAR CLONING; MOLECULAR DOCKING; NONHUMAN; PROMOTER REGION; PROTEIN MODIFICATION; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; TRANSGENE; VACCINE PRODUCTION; VIRAL GENE THERAPY; VIRUS PARTICLE; VIRUS PURIFICATION; VIRUS STRAIN; X LINKED SEVERE COMBINED IMMUNODEFICIENCY;

ANIMALS; BACULOVIRIDAE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS;

EUKARYOTA;

EID: 41749102204     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652308783688509     Document Type: Review

References (159)

1. Smith GE, Summers MD, Fraser MJ Production of human beta interferon in insect cells infected with a baculovirus expression vector. Mol Cell Biol 3: 2156-2165 (1983).
2. Summers MD. Milestones leading to the genetic engineering of baculoviruses as expression vector systems and viral pesticides. Adv Virus Res 68: 3-73 (2006).
3. Kost TA, Condreay JP. Recombinant baculoviruses as expression vectors for insect and mammalian cells. Curr Opin Biotechnol 10: 428-433 (1999).
4. Tjia ST, Altenschildesche GNIZ, Doerfler W. Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells. Virology 125: 107-117 (1983).
5. Volkman LE, Goldsmith PA. In vitro study of Autographa californica nuclear polyhedrosis virus interaction with nontarget vertebrate host cells. Appl Environ Microbiol 45: 1085-1093 (1983).
6. Carbonell LF, Klowden MJ, Miller LK. Baculovirus-mediated expression of bacterial genes in dipteran and mammalian cells. J Virol 56: 153-160 (1985).
7. Hofmann C, Sandig V, Jennings G, Rudolph M, Schlag P, Strauss M. Efficient gene-transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci USA 92: 10099-10103 (1995).
8. Boyce FM, Bucher NLR. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 93: 2348-2352 (1996).
9. Shoji I, Aizaki H, Tani H, et al. Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J Gen Virol 78: 2657-2664 (1997).
10. Wagle M, Jesuthasan S. Baculovirus-mediated gene expression in zebrafish. Marine Biotechnol 5: 58-63 (2003).
11. Ping WX, Ge JP, Li SX, et al. Baculovirus-mediated gene expression in chicken primary cells. Avian Dis 50: 59-63 (2006).
12. Grassi G, Kohn H, Dapas B, et al. Comparison between recombinant baculo- and adenoviral-vectors as transfer system in cardiovascular cells. Arch Virol 151: 255-271 (2006).
13. Sung L-Y, Lo W-H, Chm H-Y, et al. Modulation of chondrocyte phenotype via baculovirus-mediated growth factor expression. Biomaterials 28: 3437-3447. (2007).
14. Ho Y-C, Chung Y-C, Hwang S-M, Wang K-C, Hu Y-C. Transgene expression and differentiation of baculovirus-transduced human mesenchymal stem cells. J Gene Med 7: 860-868 (2005).
15. Ho Y-C, Lee H-P, Hwang S-M, et al. Baculovirus transduction of human mesenchymal stem cell-derived progenitor cells: variation of transgene expression with cellular differentiation states. Gene Ther 13: 1471-1479 (2006).
16. Zeng J, Du J, Zhao Y, Palanisamy N, Wang S. Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells. Stem Cells 25: 1055-1061 (2007).
17. Hofmann C, Lehnet W, Strauss M. The baculovirus system for gene delivery into hepatocytes. Gene Ther Mol Biol 1: 231-239 (1998).
18. Gronowski AM, Hilbert DM, Sheehan KCF, Garotta G, Schreiber RD. Baculovirus stimulates antiviral effects in mammalian cells. J Virol 73: 9944-9951 (1999).
19. Abe T, Hemmi H, Miyamoto H, et al. Involvement of the toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J Virol 79: 2847-2858 (2005).
20. Tani H, Nishijima, M, Ushijima, H, Miyamura T, Matsuura Y. Characterization of cell-surface determinants important for baculovirus infection. Virology 279: 343-353 (2001).
21. Condreay JP, Witherspoon SM, Clay WC, Kost TA. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci USA 96: 127-132 (1999).
22. van Loo ND, Fortunati E, Ehlert E, Rabelink M, Grosveld F, Scholte BJ Baculovirus infection of nondividing mammalian cells: mechanisms of entry and nuclear transport of capsids. J Virol 75: 961-970 (2001).
23. Long G, Pan XY, Kormelink R, Vlak JM. Functional entry of baculovirus into insect and mammalian cells is dependent on clathrin-mediated endocytosis. J Virol 80: 8830-8833 (2006).
24. Matilainen H, Rinne J, Gilbert L, Marjornaki V, Reunanen H, Oker-Blom C. Baculovirus entry into human hepatoma cells. J Virol 79: 15452-15459 (2005).
25. Barsoum J, Brown R, McKee M, Boyce FM. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum Gene Ther 8: 2011-2018 (1997).
26. Kukkonen SP, Airenne KJ, Marjomaki V, et al. Baculovirus capsid display: A novel tool for transduction imaging. Mol Ther 8: 853-862 (2003).
27. Salminen M, Airenne KJ, Rinnankoski R. et al. Improvement in nuclear entry and transgene expression of baculoviruses by disintegration of micrombules in human hepatocytes. J Virol 79: 2720-2728 (2005).
28. Vaughan EE, DeGiulio JV, Dean DA. Intracellular trafficking of plasmids for gene therapy: Mechanisms of cytoplasmic movement and nuclear import. Curr Gene Ther 6: 671-681 (2006).
29. Li Y, Wang X, Guo H, Wang S. Axonal transport of recombinant baculovirus vectors. Mol Ther 10: 1121-1129 (2004).
30. Hu Y-C, Tsai C-T, Chang Y-J, Huang J-H. Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: focuses on strategic infection and feeding. Biotechnol Prog 19: 373-379 (2003).
31. Kramer OH, Gottlicher M, Heinzel T. Histone deacetylase as a therapeutic target. Trends Endocrinol Metabol 12: 294-300 (2001).
32. Spenger A, Ernst W, Condreay JP, Kost TA, Grabherr R. Influence of promoter choice and trichostatin A treatment on expression of baculovirus delivered genes in mammalian cells. Protein Expr Purif 38: 17-23 (2004).
33. Wang K-C, Wu J-C, Chung Y-C, Ho Y-C, Chang MD, Hu Y-C. Baculovirus as a highly efficient gene delivery vector for the expression of hepatitis delta virus antigens in mammalian cells. Biotechnol Bioeng 89: 464-473 (2005).
34. Kim C-H, Yoon J-S, Sohn H-J, et al. Direct vaccination with pseudotype baculovirus expressing murine telomerase induces antitumor immunity comparable with RNA-electroporated dendritic cells in a murine glioma model. Cancer Lett 250: 276-283 (2007).
35. Kitajima M, Hamazaki H, Miyano-Kurosaki N, Takaku H. Characterization of baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mammalian cells. Biochem Biophys Res Commun 343: 378-384 (2006).
36. Lee H-P, Ho Y-C, Hwang S-M, et al. Variation of baculovirus-harbored transgene transcription among mesenchymal stem cell-derived progenitors leads to varied expression. Biotechnol Bioeng 97 649-655 (2007).
37. Lee H-P, Chen Y-L, Shen H-C, Lo W-H, Ho Y-C, Hu Y-C. Baculovirus transduction of rat articular chondrocytes: Roles of cell cycle. J Gene Med 9: 33-43 (2007).
38. Hu Y-C. Baculovirus vectors for gene therapy. Adv Virus. Res 68: 287-320 (2006).
39. Liu Y-K, Chu C-C, Wu T-Y. Baculovirus ETL promoter acts as a shuttle promoter between insect cells and mammalian cells. Acta Pharmacol Sin 27: 321-327 (2006).
40. Gao H, Wang Y, Li N, et al. Efficient gene delivery into mammalian cells mediated by a recombinant baculovirus containing a whispovirus ie1 promoter, a novel shuttle promoter between insect cells and mammalian cells. J Biotechnol 131: 138-143 (2007).
41. Nicholson LJ, Philippe M, Paine AJ, Mann DA, Dolphin CT. RNA interference mediated in human primary cells via recombinant baculoviral vectors. Mol Ther 11: 638-644 (2005).
42. Ong ST, Li F, Du J, Tan YW, Wang S. Hybrid cytomegalovirus enhancer-H1 promoter-based plasmid and baculovirus vectors mediate effective RNA interference. Hum Gene Ther 16: 1404-1412 (2005).
43. Wang C-Y, Wang S. Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter. Gene Ther 13: 1447-1456 (2006).
44. Liu B-H, Yang Y, Paton JFR, et al. GAL4-NF-kappa B fusion protein augments transgene expression from neuronal promoters in the rat brain. Mol Ther 14: 872-882 (2006).
45. Wang C-Y, Li F, Yang Y, Guo H-Y, Wu C-X, Wang S. Recombinant baculovirus containing the Diphtheria toxin A gene for malignant glioma therapy. Cancer Res 66: 5798-5806 (2006).
46. Mahonen AJ, Airenne KJ, Purola S, et al. Post-transcriptional regulatory element boosts baculovirus-mediated gene expression in vertebrate cells. J Biotechnol 131: 1-8 (2007).
47. Wang C-Y, Wang S. Adeno-associated virus inverted terminal repeats improve neuronal transgene expression mediated by baculoviral vectors in rat brain. Hum Gene Ther 16: 1219-1226 (2005).
48. Peng Y, Song J, Lu J, Chen X. The histone deacetylase inhibitor sodium butyrate inhibits baculovirus-mediated transgene expression in Sf9 cells. J Biotechnol 131: 180-187 (2007).
49. Hsu C-S, Ho Y-C, Wang K-C, Hu Y-C. Investigation of optimal transduction conditions for baculovirus-mediated gene delivery into mammalian cells. Biotechnol Bioeng 88: 42-51 (2004).
50. Ho Y-C, Chen H-C, Wang K-C, Hu Y-C. Highly efficient baculovirus-mediated gene transfer into rat chondrocytes. Biotechnol Bioeng 88: 643-651 (2004).
51. Chen Y-H, Wu J-C, Wang K-C, et al. Baculovirus-mediated production of HDV-Iike particles in BHK cells using a novel oscillating bioreactor. J Biotechnol 118: 135-147 (2005).
52. Chiang Y-W, Wu J-C, Wang K-C, Lai C-W, Chung Y-C, Hu Y-C. Efficient expression of histidine-tagged large hepatitis delta antigen in baculovirus-transduced BHK cells. World J Gastroenterol 12: 1551-1557 (2006).
53. Lu L, Yu L, Kwang J Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity. Biochem Biophys Res Commun 358: 404-409 (2007).
54. Kenoutis C, Efrose RC, Swevers L, et al. Baculovirus-mediated gene delivery into mammalian cells does not alter their transcriptional and differentiating potential but is accompanied by early viral gene expression. J Virol 80: 4135-4146 (2006).
55. Shen H-C, Lee H-P, Lo W-H, Yang D-G, Hu Y-C. Baculovirus-mediated gene transfer is attenuated by sodium bicarbonate. J Gene Med 9: 470-478 (2007).
56. Boublik Y, Di Bonito P, Jones IM. Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface. Biotechnology 13: 1079-1084 (1995).
57. Grabherr R, Ernst W, DoblhoffDier O, Sara M, Katinger H. Expression of foreign proteins on the surface of Autographa Californica nuclear polyhedrosis virus. BioTechniques 22: 730-735 (1997).
58. Jarvis DL, Garcia A, Jr. Biosynthesis and processing of the Autographa californica nuclear polyhedrosis virus gp64 protein. Virology 205: 300-313 (1994).
59. Mottershead D, van der Linden I, von Bonsdorff C-H, Keinanen K, Oker-Blom C. Baculoviral display of the green fluorescent protein and rubella virus envelope proteins. Biochem Biophys Res Commun 238: 717-722 (1997).
60. Mottershead DG, Alfthan K, Ojala K, Takkinen K, Oker-Blom C. Baculoviral display of functional scFv and synthetic IgG-binding domains. Biochem Biophys Res Commun 275: 84-90 (2000).
61. Matilainen H, Makela AR, Riikonen R. et al. RGD motifs on the surface of baculovirus enhance transduction of human lung carcinoma cells. J Biotechnol 125: 114-126 (2006).
62. Huser A, Rudolph M, Hofmann C. Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors. Nat Biotechnol 19: 451-455 (2001).
63. Raty JK, Airenne KJ, Marttila AT, et al. Enhanced gene delivery by avidin-displaying baculovirus. Mol Ther 9: 282-291 (2004).
64. Raty JK, Liimatainen T, Wirth T, et al. Magnetic resonance imaging of viral particle biodistribution in vivo. Gene Ther 13: 1440-1446 (2006).
65. Raty JK, Liimatainen T, Huhtala T, et al. SPECT/CT imaging of baculovirus biodistribution in rat. Gene Ther 14: 930-938 (2007).
66. Kitagawa Y, Tani H, Kwang C, Matsunaga LTM, Moriishi K, Matsuura Y. Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses. J Virol 79: 3639-3652 (2005).
67. Kaikkonen MU, Raty JK, Airenne KJ, Wirth T, Heikura T, Yla-Herttuala S. Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo. Gene Ther 13: 304-312 (2006).
68. Makela AR, Matilainen H, White DJ, Ruoslahti E, Oker-Blom C. Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides. J Virol 80: 6603-6611 (2006).
69. Chapple SDJ, Jones IM. Non-polar distribution of green fluorescent protein on the surface of Autographa californica nucleopolyhedrovirus using a heterologous membrane anchor. J Biotechnol 95: 269-275 (2002).
70. Borg J, Nevsten P, Wallenberg R, et al. Amino-terminal anchored surface display in insect cells and budded baculovirus using the amino-terminal end of neuraminidase. J Biotechnol 114: 21-30 (2004).
71. Ernst W, Grabherr R, Wegner D, Borth N, Grassauer A, Katinger H. Baculovirus surface display: construction and screening of a eukaryotic epitope library. Nucleic Acids Res 26: 1718-1723 (1998).
72. Facciabene A, Aurisicchio L, La Monica N. Baculovirus vectors elicit antigen-specific immune responses in mice. J Virol 78: 8663-8672 (2004).
73. Lu LQ, Ho YF, Kwang J Suppression of porcine arterivirus replication by baculovirus-delivered shRNA targeting nucleoprotein. Biochem. Biophys. Res Commun. 340: 1178-1183 (2006).
74. Kaneko H, Suzuki H, Abe T, Miyano-Kurosaki N, Takaku H. Inhibition of HIV-1 replication by vesicular stomatitis virus envelope glycoprotein pseudotyped baculovirus vector-transduced ribozyme in mammalian cells. Biochem Biophys Res Commun 349: 1220-1227 (2006).
75. Tani H, Limn CK, Yap CC, et al. In vitro and in vivo gene delivery by recombinant baculoviruses. J Virol 77: 9799-9808 (2003).
76. Ojala K, Mottershead DG, Suokko A, Oker-Blom C. Specific binding of baculoviruses displaying gp64 fusion proteins to mammalian cells. Biochem. Biophys. Res Commun 284: 777-784 (2001).
77. Kim Y-K, Park I-K, Jiang H-L, et al. Regulation of transduction efficiency by pegylation of baculovirus vector in vitro and in vivo. J Biotechnol 125: 104-109 (2006).
78. Kim Y-K, Choi JY, Yoo M-K, et al. Receptor-mediated gene delivery by folate-PEG-baculovirus in vitro. J Biotechnol 131: 353-361 (2007).
79. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4: 346-358 (2003).
80. Evans CH, Gouze E, Gouze JN, Robbins PD, Ghivizzani SC. Gene therapeutic approaches - transfer in vivo. Adv Drug Deliv Rev 58: 243-258 (2006).
81. Somia N, Verma IM. Gene therapy: Trials and tribulations. Nat Rev Genet 1: 91-99 (2000).
82. Baum C. What are the consequences of the fourth case? Mol Ther 15: 1401-1402 (2007).
83. Bangari DS, Mittal SK. Current strategies and future directions for eluding adenoviral vector immunity. Curr Gene Ther 6: 215-226 (2006).
84. Kochanek S, Clemens PR, Milani K, Chen HH, Chan S, Caskey CT. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc Natl Acad Sci USA 93: 5731-5736 (1996).
85. Zaiss AK, Muruve DA. Immune responses to adeno-associated virus vectors. Curr Gene Ther 5: 323-331 (2005).
86. Kost TA, Condreay JP, Jarvis DL. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat. Biotechnol 23: 567-575 (2005).
87. Strauss R, Huser A, Ni S, et al. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein. Mol Ther 15: 193-202 (2007).
88. Cheshenko N, Krougliak N, Eisensmith RC, Krougliak VA. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Gene Ther 8: 846-854 (2001).
89. Delaney WE, Isom HC. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Hepatology 28: 1134-1146 (1998).
90. Fipaldini C, Bellei B, La Monica N. Expression of hepatitis C virus cDNA in human hepatoma cell line mediated by a hybrid baculovirus-HCV vector. Virology 255: 302-311 (1999).
91. Delaney WE, Miller TG, Isom HC. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)- beta-2′,3′-dideoxy-3 ′-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA. Antimicrob Agents Chemother 43: 2017-2026 (1999).
92. Delaney WE, Edwards R, Colledge D, et al. Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus. Antimicrob Agents ChemoTher 45: 1705-1713 (2001).
93. Gilbert L, Valilehto O, Kirjavainen S, et al. Expression and subcellular targeting of canine parvovirus capsid proteins in baculovirus-transduced NLFK cells. FEBS Lett. 579: 385-392 (2005).
94. Ojala K, Tikka PJ, Kautto L, Kapyla P, Marjomaki V, Oker-Blom C. Expression and trafficking of fluorescent viral membrane proteins in baculovirus-transduced BHK cells. J Biotechnol 114: 165-175 (2004).
95. Condreay JP, Ames RS, Hassan NJ, et al. Baculoviruses and mammalian cell-based assays for drug screening. Adv Virus Res 68: 255-286 (2006).
96. Kost TA, Condreay JP, Ames RS, Rees S, Romanos MA. Implementation of BacMam virus gene delivery technology in a drug discovery setting. Drug Discov Today 12: 396-403 (2007).
97. Ames RS, Fornwald JA, Nuthulaganti P, et al. BacMam recombinant baculoviruses in G protein-coupled receptor drug discovery. Receptors Channels 10: 99-107 (2004).
98. Grabherr R, Ernst W, Oker-Blom C, Jones I. Developments in the use of baculoviruses for the surface display of complex eukaryotic proteins. Trends Biotechnol 19: 231-236 (2001).
99. Makela AR, Oker-Blom C. Baculovirus display: A multifunctional technology for gene delivery and eukaryotic library development. Adv Virus Res 68: 91-112 (2006).
100. Lindley KM, Su JL, Hodges PK, et al. Production of monoclonal antibodies using recombinant baculovirus displaying gp64-fusion proteins. J Immunol Methods 234: 123-135 (2000).
101. Saitoh R, Ohtomo T, Yamada Y, et al. Viral envelope protein gp64 transgenic mouse facilitates the generation of monoclonal antibodies against exogenous membrane proteins displayed on baculovirus. J Immunol Methods 322: 104-117 (2007).
102. Andersson M, Warolen M, Nilsson J, et al. Baculovirus-mediated gene transfer and recombinant protein expression do not interfere with insulin dependent phosphorylation of PKB/Akt in human SHSY-5Y and C3A cells. BMC Cell Biol 8: 6-17 (2007).
103. Pieroni L, La Monica N. Towards the use of baculovirus as a gene therapy vector. Curr Opin Mol Ther 3: 464-467 (2001).
104. Ghosh S, Parvez MK, Banerjee K, Sarin SK, Hasnain SE. Baculovirus as mammalian cell expression vector for gene therapy: An emerging strategy. Mol Ther 6: 5-11 (2002).
105. Kost TA, Condreay JP. Recombinant baculoviruses as mammalian cell gene delivery vectors. Trends Biotechnol 20: 173-180 (2002).
106. Hu Y-C. Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol Sin 26: 405-416 (2005).
107. Huser A, Hoffman CR. Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications. Am. J Pharmacogenomics. 3: 53-63 (2003).
108. Matsuo E, Tani H, Lim Ck, et al. Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus. Biochem Biophys Res Commun 340: 200-208 (2006).
109. Poomputsa K, Kittel C, Egorov A, Ernst W, Grabherr R. Generation of recombinant influenza virus using baculovirus delivery vector. J Virol Methods 110: 111-114 (2003).
110. ) 293 cells for the generation of influenza B/Lee/40. Mol Biotechnol 34: 157-164 (2006).
111. Sollerbrant K, Elmen J, Wahlestedt C, et al. A novel method using baculovirus-mediated gene transfer for production of recombinant adeno-associated virus vectors. J Gen Virol 82: 2051-2060 (2001).
112. Huang K-S, Lo W-H, Chung Y-C, et al. Combination of baculovirus-mediated gene delivery and packed-bed reactor for scalable production of adeno-associated virus. Hum Gene Ther 18: 1161-1170 (2007).
113. Airenne KJ, Hiltunen MO, Turunen MP, et al. Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery. Gene Ther 7: 1499-1504 (2000).
114. Lehtolainen P, Tyynela K, Kannasto J, Airenne KJ, Yla-Herttuala S. Baculoviruses exhibit restricted cell type specificity in rat brain: a comparison of baculovirus- and adenovirus-mediated intracerebral gene transfer in vivo. Gene Ther 9: 1693-1699 (2002).
115. Sarkis C, Serguera C, Petres S, et al. Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc Natl Acad Sci USA 97: 14638-14643 (2000).
116. Pieroni L, Maione D, La Monica N. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum Gene Ther 12: 871-881 (2001).
117. Hoare J, Waddington S, Thomas HC, Coutelle C, McGarvey MJ Complement inhibition rescued mice allowing observation of transgene expression following intraportal delivery of baculovirus in mice. J Gene Med 7: 325-333 (2005).
118. Wang L, Shan L, Yin J, Zhao M, Su D, Zhong J The activation of lytic replication of Epstein-Barr virus by baculovirus-mediated gene transduction - Brief report. Arch Virol 151: 2047-2053 (2006).
119. Aoki H, Sakoda Y, Jukuroki K, Takada A, Kida H, Fukusho A. Induction of antibodies in mice by a recombinant baculovirus expressing pseudorabies virus glycoprotein B in mammalian cells. Vet Microbiol 68: 197-207 (1999).
120. Abe T, Takahashi H, Hamazaki H, Miyano-Kurosaki N, Matsuura Y, Takaku H. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol 171: 1133-1139 (2003).
121. Yoshida S, Kondoh D, Arai E, et al. Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection. Virology 316: 161-170 (2003).
122. Chang YJ, Liu CYY, Chiang BL, Chao YC, Chen CC. Induction of IL-8 release in lung cells via activator protein-1 by recombinant baculovirus displaying severe acute respiratory syndrome-coronavirus spike proteins: Identification of two functional regions. J Immunol 173: 7602-7614 (2004).
123. Feng Q, Liu YY, Qu XX, et al. Baculovirus surface display of SARS coronavirus (SARS-CoV) spike protein and immunogenicity of the displayed protein in mice models. DNA Cell Biol 25: 668-673 (2006).
124. Yang D-G, Chung Y-C, Lai Y-K, Lai C-W, Liu H-J, Hu Y-C. Avian influenza virus hemagglutinin display on baculovirus envelope: Cytoplasmic domain affects virus properties and vaccine potential. Mol Ther 15: 989-996 (2007).
125. Hervas-Stubbs S, Rueda P, Lopez L, Leclerc C. Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol 178: 2361-2369 (2007).
126. Schutz A, Scheller N, Breinig T, Meyerhans A. The Autographa califomica nuclear polyhedrosis virus AcNPV induces functional maturation of human monocyte-derived dendritic cells. Vaccine 24: 7190-7196 (2006).
127. Chen H-C, Lee H-P, Ho Y-C, Sung M-L, Hu Y-C. Combination of baculovirus-mediated gene transfer and rotating-shaft bioreactor for cartilage tissue engineering. Biomaterials 27: 3154-3162 (2006).
128. Chen H-C, Sung L-Y, Lo W-H, et al. Combination of baculovirus-mediated BMP-2 expression and rotating-shaft bioreactor culture synergistically enhances cartilage formation. Gene Ther in press (2008).
129. Chuang C-K, Sung L-Y, Hwang S-M, Lo W-H, Chen H-C, Hu Y-C. Baculovirus as a new gene delivery vector for stem cells engineering and bone tissue engineering. Gene Ther 14: 1417-1424 (2007).
130. Merrihew RV, Clay WC, Condreay JP, Witherspoon SM, Dallas WS, Kost TA. Chromosomal integration of transduced recombinant baculovirus DNA in mammalian cells. J Virol 75: 903-909 (2001).
131. Martyn JC, Dong X, Holmes-Brown S, et al. Transient and stable expression of the HCV envelope glycoproteins in cell lines and primary hepatocytes transduced with a recombinant baculovirus. Arch Virol 152: 329-343 (2007).
132. Palombo F, Monciotti A, Recchia A, Cortese R, Ciliberto G, La Monica N. Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J Virol 72: 5025-5034 (1998).
133. Shan L, Wang LY, Yin J, Zhong P, Zhong J An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression. J Gene Med 8: 1400-1406 (2006).
134. O'Reilly D, Miller L, Luckow V. Baculovirus expression vectors: a laboratory manual, W.H. Freeman and Co, New York, (1992).
135. Shen CF, Meghrous J, Kamen A. Quantitation of baculovirus particles by flow cytometry. J Virol Methods 105: 321-330 (2002).
136. Jorio H, Tran R, Meghrous J, Bourget L, Kamen A. Analysis of baculovirus aggregates using flow cytometry. J Virol Methods 134: 8-14 (2006).
137. Transfiguracion J, Jorio H, Meghrous J, Jacob D, Kamen A. High yield purification of functional baculovirus vectors by size exclusion chromatography. J Virol Methods 142: 21-28 (2007).
138. Lo H-R, Chao Y-C. Rapid titer determination of baculovirus by quantitative real-time polymerase chain reaction. Biotechnol Prog 20: 354-360 (2004).
139. Chan Z-R, Lai C-W, Lee H-P, Chen H-C, Hu Y-C. Determination of the baculovirus transducing titer in mammalian cells. Biotechnol Bioeng 93: 564-571 (2006).
140. Tsai C-T, Chan Z-R, Lu J-T, Yang D-G, Lo W-H, Hu Y-C. Factors influencing the production and storage of baculovirus for gene delivery: An alternative perspective from the transducing titer assay. Enzyme Microb Technol 40: 1345-1351 (2007).
141. Barsoum J. Concentration of recombinant baculovirus by cation-exchange chromatography. Biotechniques 26: 834-840 (1999).
142. Hu Y-C, Tsai C-T, Chung Y-C, Lu J-T, Hsu JT-A. Generation of chimeric baculovirus with histidine-tags displayed on the envelope and its purification using immobilized metal affinity chromatography. Enzyme Microb Technol 33: 445-452 (2003).
143. Wu C, Soh KY, Wang S. Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant baculovirus and baculovirus gp64 protein. Hum Gene Ther 18: 665-672 (2007).
144. Fujita R, Matsuyama T, Yamagishi J, Sahara K, Asano S, Bando H. Expression of Autographa californica multiple nucleopolyhedrovirus genes in mammalian cells and upregulation of the host β-actin gene. J Virol 80: 2390-2395 (2006).
145. Liu CYY, Wang CH, Wang JC, Chao YC. Stimulation of baculovirus transcriptome expression in mammalian cells by baculoviral transcriptional activators. J Gen Virol 88: 2176-2184 (2007).
146. Beck NB, Sidhu JS, Omiecinski CJ Baculovirus vectors repress phenobarbital-mediated gene induction and stimulate cytokine expression in primary cultures of rat hepatocytes. Gene Ther 7: 1274-1283 (2000).
147. Yap CC, Ishii K, Aizaki H, et al. Expression of target genes by coinfection with replication-deficient viral vectors. J Gen Virol 79: 1879-1888 (1998).
148. Kronschnabl M, Marschall M, Stamminger T. Efficient and tightly regulated expression systems for the human cytomegalovirus major transactivator protein IE2p86 in permissive cells. Virus Res 83: 89-102 (2002).
149. Stanbridge LJ, Dussupt V, Maitland NJ Baculoviruses as vectors for gene therapy against human prostate cancer. J Biomed Biotechnol 2003: 79-91 (2003).
150. Song SU, Shin SH, Kim SK, et al. Effective transduction of osteogenic sarcoma cells by a baculovirus vector. J Gen Virol 84: 697-703 (2003).
151. Ma L, Tamarina N, Wang Y, et al. Baculovirus-mediated gene transfer into pancreatic islet cells. Diabetes. 49: 1986-1991 (2000).
152. Dwarakanath RS, Clark CL, McElroy AK, Spector DH. The use of recombinant baculoviruses for sustained expression of human cytomegalovirus immediate early proteins in fibroblasts. Virology 284: 297-307 (2001).
153. Cheng T, Xu C-Y, Wang Y-B, et al. A rapid and efficient method to express target genes in mammalian cell by baculovirus. World J Gastroenterol 10: 1612-1618 (2004).
154. Gao R, McCormick CJ, Arthur MJP, et al. High efficiency gene transfer into cultured primary rat and human hepatic stellate cells using baculovirus vectors. Liver 22: 15-22 (2002).
155. Wang X, Wang C, Zeng J, et al. Gene transfer to dorsal root ganglia by intrathecal injection: effects on regeneration of peripheral nerves. Mol Ther 12: 314-320 (2005).
156. Liu X, Li K, Song J, Liang C, Wang X, Chen X. Efficient and stable gene expression in rabbit intervertebral disc cells transduced with a recombinant baculovirus vector. Spine 31: 732-735 (2006).
157. Nakamichi K, Matsumoto Y, Tohya Y, Otsuka H. Induction of apoptosis in rabbit kidney cell under high-level expression of bovine herpesvirus 1 U(s)ORF8 product. Intervirology 45: 85-93 (2002).
158. Leisy DJ, Lewis TD, Leong JAC, Rohrmann GF. Transduction of cultured fish cells with recombinant baculoviruses. J Gen Virol 84: 1173-1178 (2003).
159. Song JH, Liang CY, Chen XW. Transduction of avian cells with recombinant baculovirus. J Virol Methods 135: 157-162 (2006).